Novartis, Abbott Laboratories, and Visa Named as Top Dividend Stocks for Lifetime Passive Income

Earnings
โดย The Motley Fool·Read original
Summary · why it matters

Novartis, Abbott Laboratories, and Visa are highlighted as three dividend stocks capable of sustaining consistent payout growth over the long term. Novartis is navigating the largest patent expiry in its history, yet second-quarter net sales rose 3% year over year to $14.4 billion, supported by newer products like Kesimpta and Fabhalta, and it has increased dividends for 29 consecutive years with a forward yield of 3%. Abbott Laboratories, a Dividend King with at least 50 straight annual payout increases, is seeing strength in its medical device segment led by the FreeStyle Libre continuous glucose monitoring franchise and has bolstered its diagnostics unit through an acquisition in cancer diagnostics. Visa, which has raised its dividend every year since going public in 2008, continues to grow revenue and earnings while leveraging its vast network and integrating buy-now-pay-later capabilities to fend off competition and legal challenges.

Impact on stocks 3

Biotech & Genomic Medicine▲ · 2 stocks
Abbott Laboratories
ABT
▲ PositiveDemandrelevance

Strength in medical device segment led by FreeStyle Libre and diagnostics bolstered by cancer diagnostics acquisition.

Novartis AG
NOVN
▲ PositiveDemandrelevance

Second-quarter net sales rose 3% to $14.4B, supported by newer products Kesimpta and Fabhalta.

Digital Finance & Tokenization▲ · 1 stocks
Visa Inc. Class A
V
▲ PositiveCapitalrelevance

Consistent dividend growth and revenue/earnings growth, with buy-now-pay-later capabilities to fend off competition.

© 2026 MarketDXNews